The treatment and prevention of deep vein thrombosis in the preoperative management of patients who have neurologic diseases

被引:8
|
作者
Farray, D
Carman, TL
Fernandez, BB
机构
[1] Cleveland Clin, Dept Cardiol, Weston, FL 33331 USA
[2] Jobst Vasc Ctr, Dept Vasc Med, Toledo, OH 43606 USA
[3] Loyola Univ, Ctr Med, Cardinal Bernadin Canc Ctr, Maywood, IL 60153 USA
关键词
D O I
10.1016/j.ncl.2004.01.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Both the prevention and treatment of venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), can present a significant challenge to practitioners involved in the perioperative care of patients with neurologic diseases. These patients may have an increased risk of VTE due to limb paralysis, stroke, or immobility; in an acute setting, they may have a prothrombotic tendency due to release of brain tissue thromboplastin following neurologic injury. Factors such as previous VTE, malignancy, trauma, obesity, indwelling venous catheters, and hormone use may add to the overall risk. The underlying neurologic condition, the planned surgery and risk of VTE, or the presenting thrombotic event may all impact both the choice for prophylaxis and treatment.
引用
收藏
页码:423 / +
页数:18
相关论文
共 50 条
  • [1] Management of gynecologic oncology patients with a preoperative deep vein thrombosis
    Hoffman, MS
    DeCesare, S
    Fiorica, JV
    Roberts, WS
    Cavanagh, D
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 64 (01) : 76 - 79
  • [2] Prevention and treatment of deep vein thrombosis with ximelagatran
    Caspary, L
    Bauersachs, R
    Brehme, S
    Creutzig, A
    Harenberg, J
    Hoffmann, U
    Landgraf, H
    Schellong, S
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (30) : 1635 - 1640
  • [3] Prevention of deep vein thrombosis in medical patients
    Couturaud, F
    Leroyer, C
    LeMoigne, E
    Oger, E
    Mottier, D
    [J]. PRESSE MEDICALE, 1996, 25 (39): : 1935 - 1940
  • [4] Prevention of deep vein thrombosis in cancer patients
    Lee, Agnes Y. Y.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2007, 33 (07): : 699 - 706
  • [5] DEEP-VEIN THROMBOSIS - ETIOLOGY, PREVENTION AND MANAGEMENT
    NICOLAIDES, AN
    KALODIKI, E
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1992, 62 (08): : 599 - 600
  • [6] Preoperative prevalence of deep vein thrombosis in patients scheduled to have surgery for degenerative musculoskeletal disorders
    Sato, Keigo
    Date, Hideki
    Michikawa, Takehiro
    Morita, Mitsuhiro
    Hayakawa, Kazue
    Kaneko, Shinjiro
    Fujita, Nobuyuki
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [7] Preoperative prevalence of deep vein thrombosis in patients scheduled to have surgery for degenerative musculoskeletal disorders
    Keigo Sato
    Hideki Date
    Takehiro Michikawa
    Mitsuhiro Morita
    Kazue Hayakawa
    Shinjiro Kaneko
    Nobuyuki Fujita
    [J]. BMC Musculoskeletal Disorders, 22
  • [8] Prevention and treatment of deep vein thrombosis in cancer patient
    Voog, E
    [J]. BULLETIN DU CANCER, 1998, 85 (07) : 618 - 621
  • [9] Home treatment and secondary prevention of deep vein thrombosis
    Prandoni, P
    Mosena, L
    [J]. HAEMATOLOGICA, 2001, 86 (11) : 49 - 53
  • [10] Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis
    Barrett, JS
    Gibiansky, E
    Hull, RD
    Planès, A
    Pentikis, H
    Hainer, JW
    Hua, TA
    Gastonguay, M
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2001, 39 (10) : 431 - 446